Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?

被引：0

作者：

Radi, Imad ^{[1
]}

Samaha, Ramy ^{[1
]}

Hajj, Joanna El ^{[1
]}

Samaha, Hady ^{[1
]}

Kourie, Hampig Raphael ^{[1
]}

机构：

[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Fac Med, Beirut 166830, Lebanon

来源：

FUTURE ONCOLOGY | 2021年 / 17卷 / 03期

关键词：

borderline resectable; locally advanced; modified FOLFIRINOX; pancreatic cancer; pancreatic surgery; perioperative chemotherapy; ADJUVANT CHEMOTHERAPY; GEMCITABINE; RESECTION; EFFICACY;

D O I：

10.2217/fon-2020-0836

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：229 / 233

页数：5

共 34 条

[31] Effects of duration of initial treatment on postoperative complications in pancreatic cancer
Yamada, Suguru
Takami, Hideki
Sonohara, Fuminori
Hayashi, Masamichi
Fujii, Tsutomu
Kodera, Yasuhiro
[J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2019, 26 (06) : 235 - 241
[32] Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment
Yang, Feng
Jin, Chen
Subedi, Sabin
Lee, Chong Lek
Wang, Qiang
Jiang, Yongjian
Li, Ji
Di, Yang
Fu, Deliang
[J]. CANCER TREATMENT REVIEWS, 2012, 38 (06) : 566 - 579
[33] Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside
Yang, Feng
Jin, Chen
Jiang, Yongjian
Li, Ji
Di, Yang
Ni, Quanxing
Fu, Deliang
[J]. CANCER TREATMENT REVIEWS, 2011, 37 (08) : 633 - 642
[34] Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Yoo, Changhoon
Lee, Sang Soo
Song, Ki Byung
Jeong, Jae Ho
Hyung, Jaewon
Park, Do Hyun
Song, Tae Jun
Seo, Dong Wan
Lee, Sung Koo
Kim, Myung-Hwan
Lee, Seung Soo
Kim, Jin Hee
Jin, Hyung-seung
Park, Jin-hong
Hwang, Dae Wook
Lee, Jae Hoon
Lee, Woohyung
Chang, Heung-Moon
Kim, Kyu-pyo
Ryoo, Baek-Yeol
Kim, Song Cheol
[J]. BRITISH JOURNAL OF CANCER, 2020, 123 (03) : 362 - 368

← 1 2 3 4 →